resveratrol has been researched along with Di Guglielmo Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-David, Y; Hough, MR; Li, Y; McCaw, L; Moffat, J; Spaner, DE; Tomic, J | 1 |
| Jia, Y; Liu, K; Liu, Z; Shu, X; Wang, C; Wang, L | 1 |
| Arous, N; Bachir, D; Galacteros, F; Garel, MC; Rodrigue, CM; Romeo, PH; Smith-Ravin, J | 1 |
3 other study(ies) available for resveratrol and Di Guglielmo Disease
| Article | Year |
|---|---|
Resveratrol has anti-leukemic activity associated with decreased O-GlcNAcylated proteins.
Topics: 3T3 Cells; Acetylglucosamine; Animals; Drug Antagonism; Humans; Interferons; Leukemia, Erythroblastic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Proteins; Resveratrol; Stilbenes | 2013 |
Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Caspases; Cell Proliferation; Cell Survival; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; K562 Cells; Leucine; Leukemia, Erythroblastic, Acute; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2016 |
Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation.
Topics: Anemia, Sickle Cell; Antioxidants; Blotting, Western; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; Hemoglobins; Humans; Hydroxyurea; Leukemia, Erythroblastic, Acute; Models, Biological; Proto-Oncogene Proteins p21(ras); Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases; Stem Cells; Stilbenes; Time Factors | 2001 |